HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Firms Spread Diaper Rash, Skin Care Brands, Move Lice Kit License In Recent Deals

This article was originally published in The Rose Sheet

Executive Summary

Mission Pharmacal divested to MainPointe Pharmaceuticals topical analgesic brand Thera-Gesic and the Dr. Smith’s line of infant and adult skin protectant ointments and sprays. Randob Labs agreed to purchase the Balmex brand of baby and adult skin protectants from Moberg Pharma for $4.25m.

You may also be interested in...



OTC Sleep Aid Sales Snooze As Consumers Wake Up To Alternatives

Natural products cut into sales of OTC sleep aids as more consumers prefer naturals as non-addictive and not causing grogginess the following day, Kline & Co. research shows. OTC sleep aids posted 3.4% growth in 2016, down from 50% to 15% growth in recent years.

Moberg Sustains Derma Drive, Acquires Prestige Brands' New Skin

The Swedish firm pays $40m for the PediaCare and Fiber Choice brands in addition to New Skin Liquid Bandages, which are available in spray and liquid delivery and are "the main profitability contributor in the acquired portfolio," says CEO Peter Wolpert.

Consumer Health New Products Roundup: Abbott, Little Remedies, Lycelle OTC

MET-Rx launches products, ad campaign; TyraTech says Vamousse to lice; AllStar mouthwash, cough syrup; and more news in brief.

Topics

Related Companies

UsernamePublicRestriction

Register

RS121505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel